文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

平衡晶体液与生理盐水用于创伤复苏:系统评价与荟萃分析

Balanced crystalloids versus normal saline for trauma resuscitation: A systematic review and meta-analysis.
PubMed 文献 · Am J Emerg Med · 2025-12-25
一句话结论在合并创伤性脑损伤的创伤患者中,生理盐水较平衡晶体液与更低死亡率和更多无呼吸机天数相关;无创伤性脑损伤者两组无显著差异。

本研究为系统评价与荟萃分析,检索PubMed、Cochrane CENTRAL、Web of Science和Scopus,纳入6项英文随机对照试验共1950例创伤患者,比较平衡晶体液与生理盐水用于创伤复苏的有效性与安全性。主要终点为全因死亡率,次要终点包括急性肾损伤发生率、ICU停留时间、无呼吸机天数、肾脏替代治疗需求和碱缺失。汇总分析显示,在创伤性脑损伤患者中,生理盐水组死亡率更低(OR 1.35,95%CI 1.06–1.72,p=0.02),无呼吸机天数更多(MD -0.67天,95%CI -0.86至-0.48,p<0.00001);无创伤性脑损伤者上述终点无显著差异。两组在输液总量、急性肾损伤发生率和ICU停留时间方面无显著差异。作者认为平衡晶体液仍是创伤复苏安全合理的选择。

要点

  • 合并创伤性脑损伤的创伤患者中,生理盐水组死亡率低于平衡晶体液组(OR 1.35,95%CI 1.06–1.72,p=0.02)。
  • 合并创伤性脑损伤的创伤患者中,生理盐水组无呼吸机天数多于平衡晶体液组(MD -0.67天,95%CI -0.86至-0.48,p<0.00001)。
  • 无创伤性脑损伤的创伤患者中,生理盐水与平衡晶体液在全因死亡率上无显著差异(OR 1.17,95%CI 0.47–2.90,p=0.74)。
  • 无创伤性脑损伤的创伤患者中,两组无呼吸机天数无显著差异(MD 3.0天,95%CI -3.36至9.36,p=0.36)。
  • 两组在输液总量、急性肾损伤发生率和ICU停留时间方面无显著差异;作者认为平衡晶体液仍是创伤复苏安全合理的选择。

适用人群与场景

  • 创伤患者,来自6项随机对照试验共1950例,分析中按是否合并创伤性脑损伤分层。

研究设计与关键结果

  • 系统评价与荟萃分析,纳入6项英文随机对照试验共1950例创伤患者,检索PubMed、Cochrane CENTRAL、Web of Science和Scopus,使用RevMan 5.4.1分析,Cochrane ROB-2评估偏倚。
  • 主要终点全因死亡率:合并创伤性脑损伤患者中生理盐水组死亡率低于平衡晶体液组(OR 1.35,95%CI 1.06–1.72,p=0.02);无创伤性脑损伤患者中两组无显著差异(OR 1.17,95%CI 0.47–2.90,p=0.74)。
  • 无呼吸机天数:合并创伤性脑损伤患者中生理盐水组多于平衡晶体液组(MD -0.67天,95%CI -0.86至-0.48,p<0.00001);无创伤性脑损伤患者中两组无显著差异(MD 3.0天,95%CI -3.36至9.36,p=0.36)。
  • 两组在输液总量、急性肾损伤发生率和ICU停留时间方面无显著差异。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入6项随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在合并创伤性脑损伤的创伤患者中,生理盐水较平衡晶体液与更低死亡率和更多无呼吸机天数相关,可据此个体化选择复苏液体。
  • 在无创伤性脑损伤的创伤患者中,生理盐水与平衡晶体液在全因死亡率、无呼吸机天数、急性肾损伤发生率、肾脏替代治疗需求和ICU停留时间方面无显著差异,作者认为平衡晶体液仍是创伤复苏安全合理的选择。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Fluid resuscitation is a key element for the management of critical care patients. However, it is uncertain whether balanced crystalloids may be preferred over normal saline (NS) in trauma patients. Therefore, the current meta-analysis compared the efficacy and safety of balanced crystalloids with NS in trauma resuscitation.

METHODS: The online search for articles relevant to our study objective was conducted in PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus. This search was limited to randomized controlled trials (RCTs) available in English language. The primary outcome of our study was all-cause mortality, and secondary outcomes were incidence of acute kidney injury (AKI), length of intensive care unit (ICU) stay, ventilator-free days, need for renal replacement therapy (RRT), and base deficit. The statistical analyses were performed using RevMan 5.4.1, and bias assessment was performed using the Cochrane risk of bias tool (ROB-2).

RESULTS: Six distinct RCTs involving 1950 trauma patients were included. The pooled analyses revealed that NS was associated with decreased mortality in traumatic brain injury (TBI) patients (OR: 1.35; 95 % CI: 1.06 to 1.72; p = 0.02), but not in trauma patients without TBI (OR: 1.17; 95 % CI: 0.47 to 2.90; p = 0.74). Similarly, more ventilator-free days were observed in the NS group than in the balanced crystalloids group among TBI patients (MD: -0.67 days; 95 % CI: -0.86 to -0.48; p < 0.00001), but not in trauma patients without TBI (MD: 3.0 days; 95 % CI: -3.36 to 9.36; p = 0.36). On the other hand, no significant difference was observed in total volume of study fluid administered, AKI incidence and length of ICU stay among patients with or without TBI.

CONCLUSIONS: In trauma patients with TBI, NS was associated with lower mortality and more ventilator-free days than balanced crystalloids, whereas no significant difference was noted in trauma populations without TBI. Moreover, there was no significant difference between NS and balanced crystalloids in terms of AKI incidence, need for RRT, and ICU stay, suggesting that balanced crystalloids remain a safe and reasonable option for trauma resuscitation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Zaki HA, Elmelliti H, Shaban A, et al. Balanced crystalloids versus normal saline for trauma resuscitation: A systematic review and meta-analysis. Am J Emerg Med. 2025. PMID: 41475037. doi:10.1016/j.ajem.2025.12.030

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。